Athena Adopts ASCO's HL7-Approved Electronic Data Sharing Guide

By adopting ASCO's electronic data-sharing guide for it's breast cancer treatment, Athena hopes to improve coordination of care, registration submission and research.
Published Online: April 30, 2014

Athena Breast Health Network (Athena) has adopted the ASCO’s Health Level Seven International (HL7®)-approved guide for sharing electronic data for breast cancer treatment. The Guide was developed by ASCO and approved through HL7 to become a national data exchange standard. With the Guide, Athena can utilize structured data capture tools for coordination of care, registry submission, and research.

“ASCO applauds the leadership of both Athena and the Institute for Population Health Improvement in adopting this data sharing treatment plan and guide,” said ASCO President Clifford A. Hudis, MD, FACP. “Their use of these standards will help physicians and practices move towards secure sharing of electronic information, so that they can improve patient care.”

EHRs often contain data that cannot easily be shared among physicians or contributed to quality improvement, public health reporting or analytics. In addition, the current exchange standards did not include disease-specific templates needed for continuity of cancer care. To fill this void, ASCO hosted a Data Interoperability Standards Summit in February 2013 to encourage collaboration in developing standards that will overcome these barriers. The Society selected adjuvant treatment for breast cancer as the focus for the first oncology standard. The draft standard was approved by open ballot through HL7, an accredited Standards Developing Organization (SDO) and the leading global SDO focused solely on health care, in May 2013.

Read the press release here:

Source: ASCO

Recommended Articles
A study published in JAMA Oncology presents a new tool that can predict disease recurrence in oropharyngeal cancer patients.
Proposed mergers of Aetna and Humana, and Anthem and Cigna, raise questions of whether consumers will continue to see competition in health insurance markets.
Urologists at Cancer Research UK have identified 5 distinct genomic signatures in prostate cancer that can have important implications on treatment decisions.
Fifty years ago today, President Lyndon B. Johnson signed the law that created Medicare and Medicaid, setting in motion not only the greatest change in healthcare in the nation's history at that point, but also a lasting change for society.
New research studies show that anti-inflammatory agents can improve survival as well as quality of life in cancer patients.